Showing results (131-140 of 169) with videos related to
Sort By:
Pageof 17
Journal of Reconstructive Microsurgery|May 1, 1997
A new experimental model of a true myocutaneous flap in the rat: the gluteus maximus myocutaneous flapM N Battal, Y Hata, K Matsuka, et al.Journal of the American Chemical Society|July 18, 2001
Catalytic effects of dioxygen on intramolecular electron transfer in radical ion pairs of zinc porphyrin-linked fullerenesS Fukuzumi, H Imahori, H Yamada, et al.Burns : Journal of the International Society for Burn Injuries|May 1, 1997
Effect of a prostaglandin I2 analogue, beraprost sodium, on burn-induced gastric mucosal injury in ratsM N Battal, Y Hata, K Matsuka, et al.In Vivo (Athens, Greece)|June 23, 2022
Contact Co-culture of Osteoblasts and Sympathetic Neuronal Cells Promotes Differentiation of Both Cell TypesMasahiko Okubo, K O Ito, Fumie Yamazaki, et al.Kaku Igaku. the Japanese Journal of Nuclear Medicine|August 31, 1999
[Development of 18F-FDG ([F-18]-2-fluoro-2-deoxy-D-glucose) injection for imaging of tumor reflecting glucose metabolism--results of preclinical studies]S Ino, T Shimada, M Kanagawa, et al.The Tohoku Journal of Experimental Medicine|January 1, 1994
Electrophysiological analysis of effect of propranolol in rabbit S2 proximal straight tubuleY Kondo, Y Igarashi, K Kudo, et al.Journal of the American Chemical Society|July 18, 2001
Modulating charge separation and charge recombination dynamics in porphyrin-fullerene linked dyads and triads: Marcus-normal versus inverted regionH Imahori, K Tamaki, D M Guldi, et al.Journal of Cardiovascular Pharmacology|January 1, 1996
Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertensionM Miyata, Y Ueno, H Sekine, et al.Immunopharmacology and Immunotoxicology|November 1, 1995
Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang)M Harada, K Seta, O Ito, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Th1 type CD4+ T cells may be a potent effector against poorly immunogenic syngeneic tumorsH Terao, M Harada, S Kurosawa, et al.Pageof 17